Readmission and adverse outcomes after percutaneous coronary intervention in patients with dementia
- PMID: 36409823
- PMCID: PMC10089937
- DOI: 10.1111/jgs.18120
Readmission and adverse outcomes after percutaneous coronary intervention in patients with dementia
Abstract
Background: As the population ages, clinicians increasingly encounter ischemic heart disease in patients with underlying dementia. Therefore, we quantified differences in inhospital adverse events and 30-day readmission rates among patients with and without dementia undergoing percutaneous coronary intervention (PCI).
Methods: Using the National Readmissions Database 2017-2018, we identified 755,406 index hospitalizations in which PCI was performed, of which 17,309 (2.3%) had a diagnosis of dementia. After propensity score matching patients with and without dementia, we assessed 30-day readmission and inhospital adverse events by Cox proportional hazards and logistic regression modeling and compared them with those of other common cardiac (pacemaker placement [PP]) and noncardiac (hip replacement surgery [HRS]) procedures.
Results: Thirty-day readmission was significantly higher in patients with dementia than patients without dementia (hazard ratio [HR] 1.67, 95% confidence interval [CI] 1.60-1.74). Patients with dementia also experienced higher odds of delirium (odds ratio [OR] 4.37, CI 3.69-5.16), inhospital mortality (OR 1.15, CI 1.01-1.30), cardiac arrest (OR 1.19, CI 1.01-1.39), acute kidney injury (OR 1.30, CI 1.21-1.39), and fall (OR 2.51, CI 2.06-3.07). On multivariable Cox modeling, dementia independently predicted 30-day readmission (HR 1.14, CI 1.07-1.20). The higher readmission risk with PCI (11%) among those with dementia was similar to that of patients undergoing PP (10%), but lower than in those undergoing HRS (41%).
Conclusion: Patients with dementia who undergo PCI experience significantly increased rates of inhospital delirium, mortality, kidney injury, falls, and 30-day readmission. These adverse outcomes should be considered during shared decision-making with patients and their families.
Keywords: PCI; coronary; dementia; readmission.
© 2022 The American Geriatrics Society.
Conflict of interest statement
Conflict of interest
Dr. Nanna reports funding from the American College of Cardiology Foundation supported by the George F. and Ann Harris Bellows Foundation and from the National Institute on Aging/National Institutes of Health from R03AG074067 (GEMSSTAR award). Graphical abstract was created with icons from BioRender.
Figures



Comment in
-
It is time to be heard and understood: Readmission probably is not the outcome that matters among people with dementia considering percutaneous coronary intervention.J Am Geriatr Soc. 2023 Apr;71(4):1017-1020. doi: 10.1111/jgs.18266. Epub 2023 Feb 10. J Am Geriatr Soc. 2023. PMID: 36762687 No abstract available.
References
-
- Alkhouli M, Alqahtani F, Kalra A, et al. Trends in Characteristics and Outcomes of Patients Undergoing Coronary Revascularization in the United States, 2003–2016. JAMA Netw Open 2020;3: e1921326. - PubMed
-
- von Strauss E, Viitanen M, De Ronchi D, Winblad B, Fratiglioni L. Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians. Arch Neurol 1999;56: 587–592. - PubMed
-
- Public Health Agency of Canada. Dementia and ischemic heart disease comorbidity among Canadians aged 65 years and older: Highlights from the Canadian Chronic Disease Surveillance System 2021.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous